CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.340
-0.180 (-7.14%)
Oct 29, 2024, 4:00 PM EDT - Market closed

CytoMed Therapeutics Market Cap

CytoMed Therapeutics has a market cap or net worth of $27.00 million as of October 29, 2024. Its market cap has decreased by -33.65% in one year.

Market Cap
27.00M
Enterprise Value
22.29M
1-Year Change
-33.65%
Ranking
Category
Stock Price
$2.34

Market Cap Chart

Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $27.00M, a decrease of -41.45%. That is a compound annual growth rate of -29.32%.

History

DateMarket Cap% Change
Oct 28, 202429.50M-47.79%
Dec 29, 202356.50M22.51%
View and export this data all the way back to 2023. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
FibroGen 30.00M
Onconetix 29.70M
Lipocine 29.68M
MiNK Therapeutics 29.62M
Femasys 29.57M
Curis 29.42M
Burning Rock Biotech 29.24M
Outset Medical 28.85M
Market Cap Rankings